A detailed history of Franklin Resources Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 50,777 shares of VNDA stock, worth $236,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,777
Previous 18,932 168.21%
Holding current value
$236,113
Previous $77,000 271.43%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.91 - $6.5 $124,513 - $206,992
31,845 Added 168.21%
50,777 $286,000
Q1 2024

May 13, 2024

BUY
$3.47 - $4.61 $2,744 - $3,646
791 Added 4.36%
18,932 $77,000
Q4 2023

Feb 09, 2024

SELL
$3.38 - $4.58 $144,498 - $195,799
-42,751 Reduced 70.21%
18,141 $76,000
Q3 2023

Nov 13, 2023

SELL
$4.28 - $6.57 $588,204 - $902,921
-137,431 Reduced 69.3%
60,892 $263,000
Q2 2023

Aug 11, 2023

BUY
$5.9 - $6.95 $209,874 - $247,225
35,572 Added 21.86%
198,323 $1.31 Million
Q1 2023

May 12, 2023

BUY
$6.18 - $7.99 $5,191 - $6,711
840 Added 0.52%
162,751 $1.11 Million
Q4 2022

Feb 10, 2023

BUY
$6.87 - $10.96 $3,565 - $5,688
519 Added 0.32%
161,911 $1.2 Million
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $762,534 - $949,937
80,777 Added 100.2%
161,392 $1.59 Million
Q2 2022

Aug 11, 2022

BUY
$9.31 - $11.84 $454,923 - $578,549
48,864 Added 153.9%
80,615 $880,000
Q4 2021

Feb 11, 2022

SELL
$15.69 - $21.14 $2,290 - $3,086
-146 Reduced 0.46%
31,751 $498,000
Q3 2021

Nov 12, 2021

BUY
$15.35 - $21.27 $489,618 - $678,449
31,897 New
31,897 $546,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $263M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.